Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy (CONSIGN)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01538680 |
Recruitment Status
:
No longer available
First Posted
: February 24, 2012
Last Update Posted
: March 26, 2018
|
Sponsor:
Bayer
Information provided by (Responsible Party):
Bayer
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | No longer available |
---|---|
Primary Completion Date : | No date given |
Study Completion Date : | No date given |